Evolus Receivables Turnover from 2010 to 2024

EOLS Stock  USD 16.50  0.01  0.06%   
Evolus Receivables Turnover yearly trend continues to be comparatively stable with very little volatility. Receivables Turnover will likely drop to 4.66 in 2024. From the period from 2010 to 2024, Evolus Receivables Turnover quarterly data regression had r-value of  0.75 and coefficient of variation of  34.64. View All Fundamentals
 
Receivables Turnover  
First Reported
2010-12-31
Previous Quarter
6.61944381
Current Value
4.66
Quarterly Volatility
1.46167468
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.3 M, Interest Expense of 14.5 M or Selling General Administrative of 81.7 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
  
Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Receivables Turnover Growth Pattern

Below is the plot of the Receivables Turnover of Evolus Inc over the last few years. It is Evolus' Receivables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
Receivables Turnover10 Years Trend
Slightly volatile
   Receivables Turnover   
       Timeline  

Evolus Receivables Turnover Regression Statistics

Arithmetic Mean4.22
Geometric Mean4.02
Coefficient Of Variation34.64
Mean Deviation1.26
Median3.28
Standard Deviation1.46
Sample Variance2.14
Range3.5244
R-Value0.75
Mean Square Error1.02
R-Squared0.56
Significance0
Slope0.24
Total Sum of Squares29.91

Evolus Receivables Turnover History

2024 4.66
2022 6.62
2021 6.8
2020 5.84

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Receivables Turnover, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Receivables Turnover 6.62  4.66 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.